| Pharmaceutical Information |
| Drug Name |
Difluprednate |
| Drug ID |
BADD_D00667 |
| Description |
Difluprednate is a topical corticosteroid indicated for the treatment of infammation and pain associated with ocular surgery. It is a butyrate ester of 6(α), 9(α)-difluoro prednisolone acetate. Difluprednate is abbreviated DFBA, or difluoroprednisolone butyrate acetate. It is indicated for treatment of endogenous anterior uveiti. |
| Indications and Usage |
For the treatment of inflammation and pain associated with ocular surgery. |
| Marketing Status |
approved |
| ATC Code |
D07AC19 |
| DrugBank ID |
DB06781
|
| KEGG ID |
D01266
|
| MeSH ID |
C015808
|
| PubChem ID |
443936
|
| TTD Drug ID |
D01ZOG
|
| NDC Product Code |
26251-0003; 69097-341; 0078-0862; 46439-8738; 76282-708; 46439-8739; 49803-002 |
| UNII |
S8A06QG2QE
|
| Synonyms |
difluprednate | ENV905 | C.M.9155 | Epitopic |
|
| Chemical Information |
| Molecular Formula |
C27H34F2O7 |
| CAS Registry Number |
23674-86-4 |
| SMILES |
CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
